Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	61.69B
Revenue (ttm)	41.71B
Net Income (ttm)	3.21B
Shares Out	1.75B
EPS (ttm)	1.83
PE Ratio	19.22
Forward PE	20.20
Dividend	0.70 (1.99%)
Ex-Dividend Date	Sep 20, 2024

Volume	19,339,723
Average Volume	8,938,317
Open	34.45
Previous Close	33.98
Day's Range	33.98 - 35.67
52-Week Range	25.96 - 39.15
Beta	0.64
RSI	58.94
Earnings Date	Apr 11, 2025

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 16,969
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2023, Huadong Medicine's revenue was 40.62 billion, an increase of 7.71% compared to the previous year's 37.71 billion. Earnings were 2.84 billion, an increase of 13.59%.